Gene Expression Meta-Analysis of Potential Metastatic Breast Cancer Markers

Overview

Journal Curr Mol Med

Publisher Bentham Science Publishers

Specialty Molecular Biology

Date 2017 Aug 8

PMID 28782484

Citations 31

Authors

R Bell

R Barraclough

O Vasieva

Affiliations

Soon will be listed here.

Abstract

Background: Breast cancer metastasis is a highly prevalent cause of death for European females. DNA microarray analysis has established that primary tumors, which remain localized, differ in gene expression from those that metastasize. Crossanalysis of these studies allow to revile the differences that may be used as predictive in the disease prognosis and therapy.

Objective: The aim of the project was to validate suggested prognostic and therapeutic markers using meta-analysis of data on gene expression in metastatic and primary breast cancer tumors.

Method: Data on relative gene expression values from 12 studies on primary breast cancer and breast cancer metastasis were retrieved from Genevestigator (Nebion) database. The results of the data meta-analysis were compared with results of literature mining for suggested metastatic breast cancer markers and vectors and consistency of their reported differential expression.

Results: Our analysis suggested that transcriptional expression of the COX2 gene is significantly downregulated in metastatic tissue compared to normal breast tissue, but is not downregulated in primary tumors compared with normal breast tissue and may be used as a differential marker in metastatic breast cancer diagnostics. RRM2 gene expression decreases in metastases when compared to primary breast cancer and could be suggested as a marker to trace breast cancer evolution. Our study also supports MMP1, VCAM1, FZD3, VEGFC, FOXM1 and MUC1 as breast cancer onset markers, as these genes demonstrate significant differential expression in breast neoplasms compared with normal breast tissue.

Conclusion: COX2 and RRM2 are suggested to be prominent markers for breast cancer metastasis. The crosstalk between upstream regulators of genes differentially expressed in primary breast tumors and metastasis also suggests pathways involving p53, ER1, ERB-B2, TNF and WNT, as the most promising regulators that may be considered for new complex drug therapeutic interventions in breast cancer metastatic progression.

Citing Articles

On discovery of novel hub genes for ER+ and TN breast cancer types through RNA seq data analyses and classification models.

Saddiqa A, Zakir M, Sheikh M, Muneer Z, Hassan A, Ali I Sci Rep. 2024; 14(1):20840.

PMID: 39242688 PMC: 11379961. DOI: 10.1038/s41598-024-69721-9.

The Overexpression of NUSAP1 and GTSE1 Could Predict An Unfavourable Prognosis and Shorter Disease Free Survival in ccRenal Cell Carcinoma.

El-Hussieny M, Thabet D, Tawfik H, Gayyed M, Toni N Asian Pac J Cancer Prev. 2024; 25(7):2551-2559.

PMID: 39068590 PMC: 11480612. DOI: 10.31557/APJCP.2024.25.7.2551.

Male Breast Cancer: Current Scenario and Future Perspectives.

Chidambaram A, Prabhakaran R, Sivasamy S, Kanagasabai T, Thekkumalai M, Singh A Technol Cancer Res Treat. 2024; 23:15330338241261836.

PMID: 39043043 PMC: 11271170. DOI: 10.1177/15330338241261836.

Organ-Specificity of Breast Cancer Metastasis.

Ibragimova M, Tsyganov M, Kravtsova E, Tsydenova I, Litviakov N Int J Mol Sci. 2023; 24(21).

PMID: 37958607 PMC: 10650169. DOI: 10.3390/ijms242115625.

Transcriptome Profiling Analysis of Breast Cancer Cell MCF-7 Treated by Sesamol.

Wu J, Luo D, Xu J Breast Cancer (Dove Med Press). 2023; 15:391-401.

PMID: 37274057 PMC: 10238551. DOI: 10.2147/BCTT.S392480.

References

Stark A, Tongers K, Maass N, Mehdorn H, Held-Feindt J . Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. J Cancer Res Clin Oncol. 2004; 131(3):191-8. DOI: 10.1007/s00432-004-0629-9. View

Madureira P, Varshochi R, Constantinidou D, Francis R, Coombes R, Yao K . The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells. J Biol Chem. 2006; 281(35):25167-76. DOI: 10.1074/jbc.M603906200. View

Davies B, Davies M, Gibbs F, Barraclough R, Rudland P . Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene. 1993; 8(4):999-1008. View

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Zhang X, Huang D, Guo G, Chen G, Zhang H, Wan L . Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer. BMC Cancer. 2008; 8:4. PMC: 2253544. DOI: 10.1186/1471-2407-8-4. View

OHanlon D, Fitzsimons H, Lynch J, Tormey S, Malone C, Given H . Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. Eur J Cancer. 2002; 38(17):2252-7. DOI: 10.1016/s0959-8049(02)00218-6. View

Przybylowska K, Kluczna A, Zadrozny M, Krawczyk T, Kulig A, Rykala J . Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Breast Cancer Res Treat. 2005; 95(1):65-72. DOI: 10.1007/s10549-005-9042-6. View

Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

Oates A, Barraclough R, Rudland P . The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene. 1996; 13(1):97-104. View

10.

Bailey J, Singh P, Hollingsworth M . Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins. J Cell Biochem. 2007; 102(4):829-39. DOI: 10.1002/jcb.21509. View

11.

Marsden C, Wright M, Carrier L, Moroz K, Rowan B . Disseminated breast cancer cells acquire a highly malignant and aggressive metastatic phenotype during metastatic latency in the bone. PLoS One. 2012; 7(11):e47587. PMC: 3500091. DOI: 10.1371/journal.pone.0047587. View

12.

Ma X, Dahiya S, Richardson E, Erlander M, Sgroi D . Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 2009; 11(1):R7. PMC: 2687710. DOI: 10.1186/bcr2222. View

13.

Ahmad A, Wang Z, Kong D, Ali S, Li Y, Banerjee S . FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Res Treat. 2009; 122(2):337-46. DOI: 10.1007/s10549-009-0572-1. View

14.

Merdad A, Karim S, Schulten H, Dallol A, Buhmeida A, Al-Thubaity F . Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis. Anticancer Res. 2014; 34(3):1355-66. View

15.

Su J, Shih J, Yen M, Jeng Y, Chang C, Hsieh C . Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res. 2004; 64(2):554-64. DOI: 10.1158/0008-5472.can-03-1301. View

16.

Girardini J, Napoli M, Piazza S, Rustighi A, Marotta C, Radaelli E . A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. Cancer Cell. 2011; 20(1):79-91. DOI: 10.1016/j.ccr.2011.06.004. View

17.

Al Saleh S, Al Mulla F, Luqmani Y . Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells. PLoS One. 2011; 6(6):e20610. PMC: 3119661. DOI: 10.1371/journal.pone.0020610. View

18.

Half E, Tang X, Gwyn K, Sahin A, Wathen K, Sinicrope F . Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res. 2002; 62(6):1676-81. View

19.

Davies M, Rudland P, Robertson L, PARRY E, Jolicoeur P, Barraclough R . Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene. 1996; 13(8):1631-7. View

20.

Park H, Gusarova G, Wang Z, Carr J, Li J, Kim K . Deregulation of FoxM1b leads to tumour metastasis. EMBO Mol Med. 2011; 3(1):21-34. PMC: 3401999. DOI: 10.1002/emmm.201000107. View